Modulation of urokinase-type and tissue-type plasminogen activator occurs at an early stage of progessing stages of chronic venous insufficiency

Acta Dermato-Venereologica

Volumn 80, Issue 3, 2000, Pages 162-166

  Peschen, M ^a   Rogers, A A ^a   Chen, W Y J ^a   Vanscheidt, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Microcirculation; Phlebology; Plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HYPERPIGMENTATION; LEG ULCER; LIPODERMATOSCLEROSIS; MALE; PHLEBOLOGY; PRIORITY JOURNAL; SKIN BIOPSY; TELANGIECTASIA; ZYMOGRAPHY;

EID: 0033811041     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155500750042880     Document Type: Article

References (35)

1. Microvascular changes in venous disease: An update
2. Chronic venous insufficiency disease
3. Immunohistochemistry and molecular biology of skin with chronic venous insufficiency and venous ulceration
4. Expression of the adhesion molecules ICAM-1, VCAM-1, and E- selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers
5. Changes of cytokeratin expression in the epidermis with chronic venous insufficiency
6. Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor beta 3 expression in the skin with chronic venous insufficiency
7. Increased expression of platelet derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin with chronic venous insufficiency
8. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency
9. Lipodermatosclerosis and the significance of proteolytic remodeling in the pathogenesis of venous ulceration
10. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers
11. Involvement of proteolytic enzymes - Plasminogen activators and matrix metalloproteinases - In the pathophysiology of pressure ulcers
12. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
13. Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers
14. Expression of tissue-type and urokinasetype plasminogen activator activities in chronic venous leg ulcers
15. Reporting standards in venous disease: An update. International Consensus Committee on Chronic Venous Disease
16. Classification and grading of chronic venous disease in the lower limbs. A consensus statement
17. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney
18. Amiloride selectively inhibits the urokinasetype plasminogen activator
19. Plasminogen activation in healing human wounds
20. Studies of growth factor and matrix proteinase activities during early stages of wound healing
21. Role of fibrin and plasminogen activators in repair-associated angiogenesis: In vitro studies with human endothelial cells
22. Expression of plasminogen activator enzymes in psoriatic epidermis
23. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumour necrosis factor-alpha
24. Expression and distribution of laminin, fibronectin and tenascin is stage dependently modulated in the skin of chronic venous insufficiency
25. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells
26. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids
27. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers
28. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cellbound reactants
29. Microvascular changes in chronic venous insufficiency - A review
30. Computerized tomography and magnetic resonance tomography studies before and after paratibial fasciotomy
31. Modulation of osteoblast behaviour by tenascin
32. Human gingival fibroblast migration promoted by plateletderived growth factor on titanium is correlated with release of urokinase type plasminogen activator
33. Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo
34. Plasminogen activators, venous leg ulcers and reepithelialization
35. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system